Department of Gastroenterology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, China.
Departmemt of Gastroenterology, Beijing Tsinghua Changgung Hospital Medical Center, Tsinghua University, Beijing, China.
Gut Liver. 2017 Sep 15;11(5):620-627. doi: 10.5009/gnl15424.
BACKGROUND/AIMS: In recent years, endoscopic submucosal tunnel dissection (ESTD) has gained popularity worldwide. The aim of this study was to evaluate the safety and efficacy of ESTD in treating upper gastrointestinal submucosal tumors (SMTs) in a large-volume endoscopic center.
Patients with SMTs were enrolled in this study between January 2012 and January 2015. Demographic data, clinical data, and treatment outcome were collected and analyzed.
Seventy SMTs originating from the muscularis propria (MP) layer were identified in 69 patients. All patients successfully underwent the ESTD procedure. The mean procedure time was 49.0±29.5 minutes, and the mean tumor size was 18.7±7.2 mm. Among all lesions, the majority (70.0%) were located in the esophagus, 12.9% in the cardia, and 17.1% in the stomach. Complete resection was achieved in 67 lesions (95.7%). Perforation occurred in three patients (4.3%), who were treated by endoclips. Pneumothorax occurred in two patients (2.9%) and was successfully managed by thoracic drainage. During a median follow-up of 18.1 months, patients were free of local recurrence or distant metastasis.
Our results demonstrated the feasibility and safety of ESTD in treating upper gastrointestinal SMTs originating from the MP layer. Large-scale comparative studies with other treatment methods should be conducted in the future.
背景/目的:近年来,内镜黏膜下隧道剥离术(ESTD)在全球范围内得到了广泛应用。本研究旨在评估在大容量内镜中心应用 ESTD 治疗上消化道黏膜下肿瘤(SMT)的安全性和有效性。
本研究纳入了 2012 年 1 月至 2015 年 1 月期间在我院接受治疗的 SMT 患者。收集并分析了患者的人口统计学数据、临床资料和治疗结果。
69 例患者共 70 个起源于固有肌层(MP)的 SMT 接受了 ESTD 治疗。所有患者均成功完成了 ESTD 手术。手术平均用时 49.0±29.5 分钟,肿瘤平均大小为 18.7±7.2mm。所有病变中,食管占 70.0%,贲门占 12.9%,胃占 17.1%。67 个病灶(95.7%)达到完全切除。3 例(4.3%)患者发生穿孔,均采用内镜夹闭治疗。2 例(2.9%)患者发生气胸,均经胸腔引流成功处理。中位随访 18.1 个月期间,患者无局部复发或远处转移。
本研究结果表明,ESTD 治疗起源于 MP 层的上消化道 SMT 是安全可行的。未来应开展与其他治疗方法的大规模对比研究。